Trimo San

Oxyquinoline Sulfate And Sodium Lauryl Sulfate


Coopersurgical, Inc.
Human Prescription Drug
NDC 59365-5030
Trimo San also known as Oxyquinoline Sulfate And Sodium Lauryl Sulfate is a human prescription drug labeled by 'Coopersurgical, Inc.'. National Drug Code (NDC) number for Trimo San is 59365-5030. This drug is available in dosage form of Jelly. The names of the active, medicinal ingredients in Trimo San drug includes Oxyquinoline Sulfate - .25 mg/g Sodium Lauryl Sulfate - .1 mg/g . The currest status of Trimo San drug is Active.

Drug Information:

Drug NDC: 59365-5030
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Trimo San
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Oxyquinoline Sulfate And Sodium Lauryl Sulfate
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Coopersurgical, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Jelly
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:OXYQUINOLINE SULFATE - .25 mg/g
SODIUM LAURYL SULFATE - .1 mg/g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:VAGINAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Apr, 1977
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:CooperSurgical, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:999638
999640
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:61VUG75Y3P
368GB5141J
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
59365-5030-0113.4 g in 1 TUBE (59365-5030-0)01 Apr, 1977N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Trimo san oxyquinoline sulfate and sodium lauryl sulfate oxyquinoline sulfate oxyquinoline sodium lauryl sulfate lauryl sulfate citric acid monohydrate sodium citrate methylparaben trolamine

Warnings:

W arning: chemicals in various preparations can interact with the pessary material resulting in discoloration or deterioration of the pessary. trimo-san does not have a deleterious effect on any milex pessary. testing should be performed before using any other vaginal preparation with a pessary unless specifically prescribed by your healthcare professional.

General Precautions:

General information new pessary wearers should use a ½ applicator (2g) of trimo-san 3 times the first week after original insertion of pessary. use trimo-san ½ (2g) applicator twice a week thereafter unless otherwise directed by your healthcare professional. reaction or irritation caused by trimo-san is very rare, but should it occur, discontinue use. if symptoms persist or worsen, contact your healthcare professional this product is intended for multiple use by one patient only.

Use in Pregnancy:

Trimo-san and pregnancy trimo-san has not been tested for use during pregnancy. coopersurgical does not recommend the use of trimo-san during pregnancy. if you wish to become pregnant, do not use trimo-san or any other personal hygiene product vaginally (douches, vaginal sprays, jellies or suppositories), for 6 hours prior to or following intercourse. any product used within this time period could interfere with conception.

Information for Patients:

Information about trimo-san 1. trimo-san gel will not stain skin or natural fabrics. 2. trimo-san gel helps eliminate odors, which may be associated with wearing a pessary. 3. dosage of trimo-san gel may be adjusted from one-half an applicator to a full applicator to obtain the desired results without messy leakage.

Package Label Principal Display Panel:

Principal display panel ndc 59365-5030-0 trimo-san vaginal jelly set with universal applicator contents: 1 ea. 4 oz tube (113. 4 grams) and applicator rx only revised: 6/2022 principal display panel ndc 59365-5030-0 trimo-san vaginal jelly set with universal applicator contents: 1 ea. 4 oz tube (113. 4 grams) and applicator rx only


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.